Puma Biotechnology's total assets for Q3 2025 were $202.86M, an increase of 4.08% from the previous quarter. PBYI total liabilities were $87.59M for the fiscal quarter, a -2.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.